The T. Rowe Price Mid-Cap Growth strategy, which includes T. Rowe Price Institutional Mid Cap Equity Growth, remains a strong choice for patient investors thanks to a time-tested manager and investment process.
T. Rowe Price Instl Mid-Cap Equity Gr PMEGX
- NAV / 1-Day Return 68.69 / +0.81 %
- Total Assets 5.1 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.610%
- Distribution Fee Level Low
- Share Class Type Institutional
- Category Mid-Cap Growth
- Investment Style Mid Growth
- Min. Initial Investment 1.0 Mil
- Status Open
- TTM Yield 0.14%
- Turnover 29%
USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:29 PM GMT+0
Morningstar’s Analysis PMEGX
Will PMEGX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 22.2
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Marvell Technology Inc | 3.11 | 161.3 Mil | Technology |
Hologic Inc | 2.86 | 148.5 Mil | Healthcare |
Microchip Technology Inc | 2.43 | 125.9 Mil | Technology |
The Trade Desk Inc Class A | 2.41 | 125.0 Mil | Technology |
Teleflex Inc | 2.32 | 120.2 Mil | Healthcare |
Agilent Technologies Inc | 1.89 | 98.1 Mil | Healthcare |
Textron Inc | 1.88 | 97.3 Mil | Industrials |
Ball Corp | 1.81 | 93.7 Mil | Consumer Cyclical |
Veeva Systems Inc Class A | 1.75 | 90.6 Mil | Healthcare |
Avantor Inc | 1.69 | 87.6 Mil | Healthcare |